Radiation Oncology Market Size and Growth Opportunities and Forecast till 2026 - 2035
By Ameco Research Analyst Team · Last updated: November 5, 2026
Radiation Oncology Market Size, Share & Trends Report, 2026–2035
LAST UPDATED: OCTOBER 2026
The global Radiation Oncology Market size was valued at USD 9,766.5 million in 2025 and is projected to reach USD 19,392.4 million by 2035, growing at a CAGR of 7.1% from 2026 to 2035. Growth is driven by the rising number of cancer cases, aging populations, installation and replacement of linear accelerators, image-guided and adaptive radiotherapy, stereotactic treatments that cut the number of sessions, proton therapy expansion, radiopharmaceuticals and brachytherapy, and AI that speeds up treatment planning.
Radiation oncology is the medical specialty and market for using ionizing radiation to treat cancer. It includes external beam radiation therapy delivered by linear accelerators (LINACs), compact advanced radiotherapy systems, cyclotrons, synchrotrons and proton therapy systems, using techniques such as IMRT, VMAT, IGRT, 3D conformal radiotherapy, stereotactic radiosurgery and stereotactic body radiotherapy. It also includes internal radiation therapy such as high-dose rate and low-dose rate brachytherapy and systemic radiation therapy using radiopharmaceuticals, along with planning software, imaging and services.
Radiation Oncology Market Key Takeaways
Infographic: Radiation Oncology Market Size and Growth Opportunities and Forecast till 2026 - 2035 | Ameco Research
Radiation Oncology Market Report Scope
| Report Attribute | Details |
| Radiation Oncology Market Size in 2025 | USD 9,766.5 Million |
| Radiation Oncology Market Forecast by 2035 | USD 19,392.4 Million |
| Radiation Oncology Market CAGR (2026–2035) | 7.1% |
| Analysis Period | 2023–2035 |
| Base Year | 2025 |
| Forecast Period | 2026–2035 |
| Segments Covered | by Type, by Technology, and By Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Varian Medical Systems (Siemens Healthineers), Elekta AB, Accuray Incorporated, BD (C.R. Bard), Curium Pharma, Mevion Medical Systems, Inc., IsoRay Medical, Nordion Inc., and NTP Radioisotopes SOC Ltd. |
| Report Coverage | Market Trends, Drivers, Restraints, Opportunities, Competitive Analysis, Player Profiling, Regulation Analysis |
Radiation Oncology Market Size Forecast, 2023–2035
Figures for 2025–2035 extend the earlier 2021 baseline of USD 7,423 million at the report's 7.1% CAGR.
| Year | Market Size (USD Million) |
| 2023 (historical) | 8,514.5 |
| 2024 (historical) | 9,119.1 |
| 2025 (base year) | 9,766.5 |
| 2026 (forecast) | 10,459.9 |
| 2027 (forecast) | 11,202.6 |
| 2028 (forecast) | 11,997.9 |
| 2029 (forecast) | 12,849.8 |
| 2030 (forecast) | 13,762.1 |
| 2031 (forecast) | 14,739.2 |
| 2032 (forecast) | 15,785.7 |
| 2033 (forecast) | 16,906.5 |
| 2034 (forecast) | 18,106.8 |
| 2035 (forecast) | 19,392.4 |
Latest Radiation Oncology Market Trends (2026)
Adaptive and MR-guided radiotherapy
Systems that combine imaging, including MRI, with radiotherapy let clinicians adjust treatment plans to tumor and organ changes, improving accuracy and sparing healthy tissue.
AI treatment planning
AI tools automate contouring and plan creation, cutting planning time from hours to minutes and helping centers treat more patients.
Hypofractionation and stereotactic treatment
Higher doses in fewer sessions, such as stereotactic body radiotherapy, reduce visits for patients and increase machine capacity.
Proton therapy expansion
More compact and lower-cost proton systems are widening access, especially for pediatric and hard-to-treat tumors.
Radiopharmaceuticals
Radioligand therapies that deliver radiation directly to cancer cells are growing quickly, expanding systemic radiation therapy.
Access in emerging markets
Many low- and middle-income countries lack enough radiotherapy machines, and governments and international programs are funding new LINAC installations.
Radiation Oncology Market Dynamics
Growth drivers
- Rising global cancer incidence
- Aging populations
- Technological advances in precision radiotherapy
- Replacement and upgrade of radiotherapy equipment
- Growth of radiopharmaceuticals and brachytherapy
Restraints and challenges
- High cost of LINAC and proton therapy systems
- Shortage of radiation oncologists, physicists and therapists
- Limited access in low-income regions
- Side effects and safety concerns
Opportunities
Key opportunities include adaptive and AI-enabled radiotherapy, compact proton systems, radioligand therapies, service and software contracts, and new cancer centers in Asia Pacific, Latin America, the Middle East and Africa.
Radiation Oncology Market Segment Analysis
By type
The market is segmented into external beam radiation therapy (compact advanced radiotherapy systems and linear accelerators), internal beam radiation therapy (systemic beam radiation therapy and brachytherapy), cyclotron, proton therapy, synchrotron and others. External beam radiation therapy dominates, led by linear accelerators.
By technology
Technologies include external beam methods such as VMAT, 3D CRT, proton beam therapy, IGRT, stereotactic applications and IMRT; internal beam methods such as high-dose rate and low-dose rate brachytherapy; and systemic radiation therapy. External beam radiation therapy is likely to hold the largest share.
Radiation Oncology Market Regional Analysis
North America dominated with the largest revenue share and is expected to keep leading, supported by advanced cancer centers, reimbursement and early adoption of new radiotherapy technologies.
Europe is a major market with strong public cancer care and proton therapy centers. Asia Pacific is expected to grow fast, driven by rising cancer incidence and new radiotherapy centers in China, India and Japan.
Latin America and the Middle East & Africa are growing markets, with investment to close large gaps in radiotherapy access.
Radiation Oncology Market Segmentation
- External Beam Radiation Therapy (Compact Advanced Radiotherapy Systems, Linear Accelerators)
- Internal Beam Radiation Therapy (Systemic Beam Radiation Therapy, Brachytherapy)
- Cyclotron
- Proton Therapy
- Synchrotron
- Others
- External Beam Radiation Therapy (VMAT, 3D CRT, Proton Beam Therapy, IGRT, Stereotactic, IMRT)
- Internal Beam Radiation Therapy (High-Dose Rate Brachytherapy, Low-Dose Rate Brachytherapy)
- Systemic Radiation Therapy
- North America: U.S., Canada
- Europe: U.K., Germany, France, Spain, Rest of Europe
- Latin America: Brazil, Mexico, Rest of Latin America
- Asia-Pacific: China, Japan, India, Australia, South Korea, Rest of Asia-Pacific
- Middle East & Africa: GCC, South Africa, Rest of Middle East & Africa
Radiation Oncology Market Leading Companies
The radiation oncology market is led by radiotherapy equipment makers, with brachytherapy, isotope and radiopharmaceutical suppliers and treatment planning software companies. Companies compete on precision, speed, imaging integration, software, service networks and total cost of ownership. Key players profiled in this report include Varian Medical Systems (Siemens Healthineers), Elekta AB, Accuray Incorporated, BD (C.R. Bard), Curium Pharma, Mevion Medical Systems, Inc., IsoRay Medical, Nordion Inc., and NTP Radioisotopes SOC Ltd..
Varian Medical Systems (Siemens Healthineers)Elekta ABAccuray IncorporatedBD (C.R. Bard)Curium PharmaMevion Medical Systems, Inc.IsoRay MedicalNordion Inc.NTP Radioisotopes SOC Ltd.
Key Questions Answered in This Report
- What is the size of the radiation oncology market in 2025, and how large will it be by 2030 and 2035?
- What are the main growth drivers, restraints and opportunities through 2035?
- Which by type and by technology segments will grow the fastest?
- Which regions and countries offer the largest and fastest-growing opportunities?
- How are adaptive radiotherapy, AI planning and proton therapy shaping radiation oncology in 2026?
- Who are the leading companies, and what strategies are they using to compete?
Research Methodology
Ameco Research built this forecast from a mix of primary and secondary research. Analysts spoke with radiotherapy equipment makers, cancer centers, isotope suppliers, health agencies and published literature to validate pricing, volumes and demand trends, and reviewed company filings, trade statistics, regulatory documents and industry publications. The radiation oncology market size was estimated with bottom-up and top-down approaches and validated through data triangulation, with 2025 as the base year and forecasts for 2026–2035.
Related Reports
- Magnetic Resonance Imaging (MRI) Coils Market Report
- Cancer Chemotherapy Market Report
- Cancer Gene Therapy Market Report
- Vascular Imaging Market Report
- Cancer Immunotherapy Market Report
Radiation Oncology Market: Frequently Asked Questions
How big is the radiation oncology market?
The global radiation oncology market was valued at USD 9,766.5 million in 2025 and is expected to reach USD 19,392.4 million by 2035.
What is the growth rate of the radiation oncology market?
The radiation oncology market is projected to grow at a CAGR of 7.1% from 2026 to 2035.
What will the radiation oncology market be worth in 2030?
The radiation oncology market is projected to reach about USD 13,762.1 million in 2030, growing at a CAGR of 7.1%.
What is driving growth in the radiation oncology market?
Key drivers are rising cancer incidence, aging populations, advances in precision radiotherapy, equipment replacement and growth of radiopharmaceuticals.
What is radiation oncology?
Radiation oncology is the use of ionizing radiation, from external beam machines, brachytherapy or radiopharmaceuticals, to treat cancer.
Which region leads the radiation oncology market?
North America dominated the market, while Asia Pacific is expected to grow fast.
Which segment holds the largest share of the radiation oncology market?
External beam radiation therapy is the leading type, led by linear accelerators, while proton therapy and systemic radiation therapy grow fast.
What are the latest trends in the radiation oncology market?
The main 2026 trends are adaptive and MR-guided radiotherapy, aI treatment planning, hypofractionation and stereotactic treatment, proton therapy expansion, radiopharmaceuticals and access in emerging markets.
What are the main challenges in the radiation oncology market?
The main challenges are the high cost of equipment, shortages of trained staff, limited access in low-income regions and side effects.
What is the difference between external beam radiation and brachytherapy?
External beam radiation delivers radiation from a machine outside the body, while brachytherapy places a radioactive source inside or next to the tumor.
Who are the key players in the radiation oncology market?
Leading companies include Varian Medical Systems (Siemens Healthineers), Elekta AB, Accuray Incorporated, BD (C.R. Bard), Curium Pharma, Mevion Medical Systems, Inc., IsoRay Medical, Nordion Inc., and NTP Radioisotopes SOC Ltd..
Related Pharma & Healthcare Market Reports
- Virtual Reality Headset Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Pelvic Floor Electric Stimulator Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Mesenchymal Stem Cells Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Anti-Allergic Drugs Market Size and Growth Opportunities and Forecast till 2026 - 2035
- Nutrition and Weight Management Market Size and Growth Opportunities and Forecast till 2026 - 2035